» Articles » PMID: 28157188

STAT5A/5B-specific Expansion and Transformation of Hematopoietic Stem Cells

Overview
Journal Blood Cancer J
Date 2017 Feb 4
PMID 28157188
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia.

Moser B, Edtmayer S, Witalisz-Siepracka A, Stoiber D Biomedicines. 2021; 9(8).

PMID: 34440253 PMC: 8392322. DOI: 10.3390/biomedicines9081051.


JAK-STAT in Early Hematopoiesis and Leukemia.

Fasouli E, Katsantoni E Front Cell Dev Biol. 2021; 9:669363.

PMID: 34055801 PMC: 8160090. DOI: 10.3389/fcell.2021.669363.


Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.

Brachet-Botineau M, Polomski M, Neubauer H, Juen L, Hedou D, Viaud-Massuard M Cancers (Basel). 2020; 12(1).

PMID: 31963765 PMC: 7016966. DOI: 10.3390/cancers12010240.


Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in -Addicted Glioblastoma.

Liu H, Lee P, Bamodu O, Su Y, Fong I, Yeh C Cancers (Basel). 2019; 11(12).

PMID: 31783691 PMC: 6966688. DOI: 10.3390/cancers11121888.


STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.

Maurer B, Kollmann S, Pickem J, Hoelbl-Kovacic A, Sexl V Cancers (Basel). 2019; 11(11).

PMID: 31690038 PMC: 6895831. DOI: 10.3390/cancers11111726.

References
1.
Friedbichler K, Kerenyi M, Kovacic B, Li G, Hoelbl A, Yahiaoui S . Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation. Blood. 2010; 116(9):1548-58. PMC: 2938843. DOI: 10.1182/blood-2009-12-258913. View

2.
Bunting K . STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci. 2007; 12:2807-20. DOI: 10.2741/2274. View

3.
Snow J, Abraham N, Ma M, Abbey N, Herndier B, Goldsmith M . STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood. 2002; 99(1):95-101. DOI: 10.1182/blood.v99.1.95. View

4.
Schepers H, van Gosliga D, Wierenga A, Eggen B, Schuringa J, Vellenga E . STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. Blood. 2007; 110(8):2880-8. DOI: 10.1182/blood-2006-08-039073. View

5.
Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lanneree S . Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood. 2008; 112(6):2463-73. PMC: 2532813. DOI: 10.1182/blood-2007-09-115477. View